BACE inhibitors (The Genetics Co)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBACE inhibitors (The Genetics Co)
Drug Alias NameAlzheimers therapy (TGC)Alzheimers therapy (The Genetics Co)beta amyloid converting enzyme inhibitors (The Genetics Co)beta amyloid converting enzyme inhibitors (TGC)BACE inhibitors (TGC)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCallistoGen AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCallistoGen AGThe Genetics Co Inc
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A